Clinical Trial Update: Safety and Efficacy of an Anti-Psychotic in Patients With Schizophrenia [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial update reports the safety and efficacy outcomes of an antipsychotic studied in patients with schizophrenia, with the study status in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Antipsychotic (Phase 2 study)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Schizophrenia | Phase 2 | Status: COMPLETED